{
    "Trade/Device Name(s)": [
        "hema-screen ER XCELTM Enhanced Readability Fecal Occult Blood Test"
    ],
    "Submitter Information": "Immunostics, Inc.",
    "510(k) Number": "K163554",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102664"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHE"
    ],
    "Summary Letter Date": "December 15, 2016",
    "Summary Letter Received Date": "December 19, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.6550"
    ],
    "Regulation Name(s)": [
        "Occult Blood Test"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Occult blood (hemoglobin)"
    ],
    "Specimen Type(s)": [
        "Stool"
    ],
    "Specimen Container(s)": [
        "hema-screen ER XCELTM slide"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Guaiac-peroxidase reaction"
    ],
    "Methodologies": [
        "Chemical colorimetric detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Reagent",
        "Slide",
        "Patient Pack"
    ],
    "Document Summary": "FDA 510(k) summary for hema-screen ER XCELTM Enhanced Readability Fecal Occult Blood Test for qualitative detection of fecal occult blood using guaiac-peroxidase reaction",
    "Indications for Use Summary": "Rapid qualitative detection of occult blood in stool to aid in diagnosing asymptomatic gastrointestinal conditions, for use in hospital testing, colorectal cancer mass screening, and testing of postoperative patients and newborns",
    "fda_folder": "Hematology"
}